you are here: HomeNewscoronavirus

WHO Chief thanks India, PM Narendra Modi for ‘continued support to global COVID-19 response’

WHO Director General Tedros Adhanom Ghebreyesus took to Twitter on January 23 and said: “Thank you India and Prime Minister Narendra Modi for your continued support to the global COVID-19 response.

January 23, 2021 / 07:10 PM IST
WHO Director General Tedros Adhanom Ghebreyesus

WHO Director General Tedros Adhanom Ghebreyesus


The World Health Organisation (WHO) has thanked India and Prime Minister Narendra Modi for “continued support” to the global COVID-19 pandemic response that has killed more than two million people and infected over 96 million across the world.

WHO Director General Tedros Adhanom Ghebreyesus took to Twitter on January 23 and said: “Thank you India and Prime Minister Narendra Modi for your continued support to the global COVID-19 response. Only if we act together, including sharing of knowledge, can we stop this virus and save lives and livelihoods.”

India started sending COVID-19 vaccines to other countries starting January 20, including to Brazil and Brazilian President Jair M Bolsonaro has also thanked India for the help in combating the pandemic.

He tweeted: “Namaskar, Prime Minister Narendra Modi Brazil feels honoured to have a great partner to overcome a global obstacle by joining efforts. Thank you for assisting us with the vaccine exports from India to Brazil. Dhanyavaad!”

The Government of India has dispatched 2 million doses of Oxford-AstraZeneca’s Covishield COVID-19 vaccines to Brazil. Covishield is being manufactured by the Serum Institute of India.

Bangladesh, Nepal, Bhutan and Maldives have got over 3.2 million doses in total from India. Donations to Mauritius, Myanmar and Seychelles will follow and Sri Lanka and Afghanistan are next on the list.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Follow our coverage of the coronavirus crisis here
Moneycontrol News
first published: Jan 23, 2021 07:10 pm

stay updated

Get Daily News on your Browser
Sections